Lead-212 PSV359 Therapy for Patients With Solid Tumors
Perspective Therapeutics
Perspective Therapeutics
Eli Lilly and Company
Turning Point Therapeutics, Inc.
Cancer Research UK
Intensity Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
Kineta Inc.
Duke University